Associated Papers
Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.
Khorshied M et al.
Cancer Biomarkers : Section a of Disease Markers, 2021
Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma.
Alsalawy NF et al.
Journal of Medical Virology, 2018
Genetic polymorphisms and haplotypes of TRAIL gene correlate with NSCLC susceptibility in a group of Chinese patients.
Luo J et al.
International Journal of Clinical and Experimental Medicine, 2015
Association between laryngeal squamous cell carcinoma and polymorphisms in tumor necrosis factor related apoptosis induce ligand (TRAIL), TRAIL receptor and sTRAIL levels.
Verim A et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2014
There is no significant association between death receptor 4 (DR4) gene polymorphisms and lung cancer in Turkish population.
Taştemir-Korkmaz D et al.
Pathology Oncology Research : Por, 2013
TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y et al.
Molecular Cancer Research : Mcr, 2008
Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
Frank B et al.
Carcinogenesis, 2005
Select a paper to view details